In conclusion, the present study has shown that the <strong>glucose</strong>-<strong>induced</strong> <strong>suppression</strong> in <strong>glucagon</strong> levels is lost <strong>after</strong> a 50% <strong>partial</strong> pancreatectomy in humans. The changes in post- challenge <strong>glucagon</strong> levels are closely related to the impairment in insulin concentrations. These findings suggest that the defects in alpha-cell function typically observed in patients with type 2 diabetes are likely secondary to the reduction in beta-cell mass. Alterations in <strong>glucagon</strong> regulation should be considered as potential side effects of <strong>partial</strong> pancreatectomies in humans. Acknowledgements: The excellent technical assistance of Birgit Baller, Yvonne Dabrowski, Kirsten Mros, Heike Achner and Gudrun Müller is gratefully acknowledged. These studies were supported by grants from the Deutsche Forschungsgemeinschaft (DFG grant-no. Me2096/5-1 to JJM) and the Ruhr-University of Bochum (FoRUM grants to JJM). 14
References: 1. Meier JJ, Butler PC 2005 Insulin secretion. In: DeGroot LJ, Jameson JL eds. Endocrinology. 5 ed. Philadelphia: Elsevier Saunders; 961-973 2. Unger RH, Aguilar-Parada E, Muller WA, Eisentraut AM 1970 Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest 49:837- 848. 3. Lefebvre PJ 1995 Glucagon and its family revisited. Diabetes Care 18:715-730. 4. Dunning BE, Gerich JE 2007 The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocr Rev 28:253-283. Epub 2007 Apr 2004. 5. Sherwin RS, Fisher M, Hendler R, Felig P 1976 Hyper<strong>glucagon</strong>emia and blood <strong>glucose</strong> regulation in normal, obese and diabetic subjects. N Engl J Med 294:455-461. 6. Raskin P, Unger RH 1978 Hyper<strong>glucagon</strong>emia and its <strong>suppression</strong>. Importance in the metabolic control of diabetes. N Engl J Med 299:433-436. 7. Larsson H, Ahren B 2000 Glucose intolerance is predicted by low insulin secretion and high <strong>glucagon</strong> secretion: outcome of a prospective study in postmenopausal Caucasian women. Diabetologia 43:194-202. 8. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J 1992 Role of reduced <strong>suppression</strong> of <strong>glucose</strong> production and diminished early insulin release in impaired <strong>glucose</strong> tolerance. N Engl J Med 326:22-29. 9. Bennett PH, Aronoff SL, Unger RH 1976 Evidence for an insulin-independent alpha-cell abnormality in human diabetes. Metabolism 25:1527-1529. 10. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH 1973 Lack of <strong>glucagon</strong> response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 182:171-173. 11. Kirk RD, Dunn P, Smith JR, Beaven DW, Donald RA 1975 Abnormal pancreatic alpha-cell function in first-degree relatives of known diabetics. J Clin Endocrinol Metab 40:913-916. 12. Meier JJ, Deacon CF, Schmidt WE, Holst JJ, Nauck MA 2007 Suppression of <strong>glucagon</strong> secretion is lower <strong>after</strong> oral <strong>glucose</strong> administration than during intravenous <strong>glucose</strong> administration in human subjects. Diabetologia 50:806-813. Epub 2007 Feb 2016. 13. Jayapaul MK, Walker M 2007 Hyper<strong>glucagon</strong>aemia is not a primary metabolic defect in non-diabetic first-degree relatives from Type 2 diabetic families. Diabet Med 24:1050-1051. 14. Raju B, Cryer PE 2005 Loss of the decrement in intraislet insulin plausibly explains loss of the <strong>glucagon</strong> response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans. Diabetes 54:757-764. 15. Kjems LL, Kirby BM, Welsh EM, Veldhuis JD, Straume M, McIntyre SS, Yang D, Lefebvre P, Butler PC 2001 Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyper<strong>glucagon</strong>emia in the minipig. Diabetes 50:2001-2012 16. Goodner CJ, Koerker DJ, Weigle DS, McCulloch DK 1989 Decreased insulin- and <strong>glucagon</strong>-pulse amplitude accompanying beta-cell deficiency <strong>induced</strong> by streptozocin in baboons. Diabetes 38:925-931. 17. Meier JJ, Kjems LL, Veldhuis JD, Lefèbvre P, Butler PC 2006 Postprandial <strong>suppression</strong> of <strong>glucagon</strong> secretion depends on intact pulsatile insulin secretion: Further evidence for the intraislet insulin hypothesis. Diabetes 55:1051-1056 15